Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226479 · ClinicalTrials.gov registry record · NA
Non-invasive Venous Pressure Estimation
A NA study of Cardiac Intensive Care, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07226479 is a NA study of Cardiac Intensive Care that is actively recruiting participants, run by Yale University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07226479, a NA study of Cardiac Intensive Care, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The non-invasive central venous pressure estimation in adult cardiac intensive care units (CICU) patients study is a single-center, single-arm, investigator-blinded, interventional, intra-participant comparative, feasibility study. This study aims to assess the safety and preliminary accuracy of external jugular venous occlusion pressure measured non-invasively with the venous occlusion pressure monitoring device (CPMX2) in adult CICU patients. As a feasibility study, the primary goal is to gather preliminary data on the feasibility, safety, and effectiveness of the non-invasive CVP estimation method. Although single arm, the study will compare non-invasive CVP measurements with standard invasive CVP measurements taken concurrently. This intra-participant comparative approach is essential to validate the correlation and reliability of the non-invasive method.
Conditions Studied
Interventions
- DEVICE CPMX2
Study Locations (1)
Connecticut
- Yale New Haven Hospital CICU - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226479
The ClinicalTrials.gov registry entry for NCT07226479 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Intensive Care appearing as the primary indexed condition, and to 1 intervention - of which CPMX2 is the first listed.
NCT07226479 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT07226479 about?
NCT07226479 is a clinical study titled "Non-invasive Venous Pressure Estimation". The non-invasive central venous pressure estimation in adult cardiac intensive care units (CICU) patients study is a single-center, single-arm, investigator-blinded, interventional, intra-participant comparative, feasibility study. This study aims to assess the safety and preliminary accuracy of ext...
What is the current status of trial NCT07226479?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-06. Estimated completion is 2026-11.
What conditions does trial NCT07226479 study?
This clinical trial studies the following conditions: Cardiac Intensive Care.
What interventions are being tested in trial NCT07226479?
The interventions under investigation include: CPMX2 (DEVICE).
Who is sponsoring clinical trial NCT07226479?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07226479 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.